Cancer Theranostic Nanoparticles Self-Assembled from Amphiphilic Small Molecules with Equilibrium Shift-Induced Renal...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Nano drug delivery systems show promise for cancer treatment but face challenges with complete body elimination.
• Renal excretion is a preferred pathway for minimizing toxicity compared to hepatic clearance of nanoparticles.

Purpose of the Study:

• To design and evaluate in vivo renal-clearable nanoparticles for enhanced cancer therapy.
• To develop a nano drug delivery system that combines chemotherapy and magnetic resonance imaging (MRI) with a safe metabolic pathway.

Main Methods:

• Self-assembly of amphiphilic small molecules into nanoparticles capable of MRI and chemotherapy.
• Evaluation of nanoparticle accumulation in tumor tissues and subsequent renal clearance of dismantled small molecules.
• Assessment of tumor inhibition efficacy, side effects, and chronic toxicity in vivo.

Main Results:

• The constructed nanoparticles effectively accumulated in tumor tissues.
• Dismantled small molecules were efficiently cleared by the kidneys, demonstrating renal-clearability.
• The nanoparticles exhibited significant tumor inhibition with low side effects and negligible chronic toxicity.

Conclusions:

• In vivo renal-clearable nanoparticles offer a promising strategy for cancer therapy.
• This approach facilitates efficient tumor targeting and safe elimination, reducing agent-induced toxicity.
• The developed system presents a potential pathway for clinical translation of nano drug delivery systems with anticancer effects and low-toxic metabolism.